<< back to Hepatitis C by Ajoy Bose In an unprecedented move to tackle the growing epidemic of Hepatitis C in the north Indian state of Punjab, free treatment is being made available by the local administration. This initiative has been strengthened by the recent sharp drop in the price of Hep C super drug […]
Curing hepatitis C in an experiment the size of Egypt
<< back to Hepatitis C Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. Today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world. But a grand experiment unfolding across the country may change all that. […]
WHO Updates Patent Status Info For New Hepatitis C Medicines
<< back to Hepatitis C The World Health Organization has issued updated information on the patent status of hepatitis C medicines, including assessments of hurdles for affordable generic versions of latest drugs. This article in IP Watch gives a quick summary that runs through the content of the reports and links to the WHO content. […]
Gilead’s chronic hepatitis C treatment expansion
<< back to Hepatitis C Increasing access with Indian generics For more than a decade, Gilead has been working in partnership with governments, healthcare systems, providers, public health entities and generic manufacturers to make its HIV and hepatitis B medicines available worldwide. Currently, 7.6 million people living with HIV in developing countries receive Gilead antiretroviral […]
Activists vow to spread awareness on hepatitis C
<< back to Hepatitis C Across India communities are waking up to the urgency to address the silent epidemic of hepatitis C. This article from the Tribune describes the beginings of all important local activism in Mandi Ahmedgarh to commit to action and raise awareness. Office-bearers and activists of social, educational and medical organisations of […]
New Hepatitis C treatment goals – achievable or impossible?
<< back to Hepatitis C by James Snodgrass At the 69th World Health Assembly held in Geneva in May, delegates approved WHO’s draft global health sector strategy on viral hepatitis, 2016–2021. The strategy suggests that all nations affected by hepatitis should adopt five core interventions: vaccination against hepatitis B (and against hepatitis A where appropriate) […]
What can the 2030 hepatitis goals learn from polio eradication?
<< back to Hepatitis C By Jenny Kowalczuk The ambitious, draft WHO Global Health Sector Strategy on Viral Hepatitis 2016-21, was approved at the 69th World Health Assembly, in May 2016. A goal of the draft strategy is to eliminate viral hepatitis as a public health threat by 2030, and to contribute to the achievement […]